Genetics, autoantibodies and clinical features in understanding and
predicting rheumatoid arthritis
Helm-van Mil, A.H.M. van der
Citation
Helm-van Mil, A. H. M. van der. (2006, October 26). Genetics, autoantibodies and clinical
features in understanding and predicting rheumatoid arthritis. Retrieved from
https://hdl.handle.net/1887/4929
Version:
Corrected Publisher’s Version
License:
Licence agreement concerning inclusion of doctoral thesis in the
Institutional Repository of the University of Leiden
Downloaded from:
https://hdl.handle.net/1887/4929
#HA P TER¬ !"342!#4 /BJECTIVES¬2HEUMATOID¬ARTHRITIS¬2! ¬IS¬CHARACTERIZED¬BY¬INm¬AMMATION¬AND¬DESTRUCTION¬ OF¬SYNOVIAL¬JOINTS¬&IBROBLAST LIKE¬SYNOVIOCYTES¬&,3 ¬HARVESTED¬FROM¬SYNOVIAL¬TISSUE¬FROM PATIENTS¬WITH¬2!¬CAN¬INVADE¬NORMAL¬HUMAN¬CARTILAGE¬IN¬SEVERE¬COMBINED¬IMMUNODEl¬ CIENCY¬DISEASE¬3#)$ ¬MICE¬AND¬MATRIGEL¬IN¬VITRO¬4HIS¬STUDY¬WAS¬UNDERTAKEN¬TO¬INVESTIGATE THE¬ ASSOCIATION¬ OF¬ THESE¬ IN VITRO¬ CHARACTERISTICS¬ WITH¬ DISEASE¬ CHARACTERISTICS¬ IN¬ PATIENTS WITH¬2!
-ETHODS 3YNOVIAL¬ TISSUE¬ SAMPLES¬ OF¬ ¬ 2!¬ AND¬ ¬ /!¬ PATIENTS¬ WERE¬ OBTAINED¬ FROM¬
!SSOCIATION¬BETWEEN¬&,3¬INVASIVENESS¬AND¬2!¬SEVERITY ).42/$5#4)/. 2HEUMATOID¬ARTHRITIS¬2! ¬IS¬AN¬AUTOIMMUNE¬DISEASE¬WHICH¬PREDOMINANTLY¬TARGETS¬THE¬SY NOVIAL¬JOINTS¬ULTIMATELY¬LEADING¬TO¬JOINT¬DESTRUCTION¬4HE¬DESTRUCTIVE¬PROCESS¬IS¬SUGGESTED TO¬BE¬MEDIATED ¬AT¬LEAST¬IN¬PART ¬BY¬l¬BROBLAST LIKE¬SYNOVIOCYTES¬&,3 ¬FROM¬THE¬SYNOVIUM BECAUSE¬IN¬A¬SEVERE¬COMBINED¬IMMUNODEl¬CIENCY¬DISEASE¬3#)$ ¬MOUSE¬CO IMPLEMENTA TION¬ MODEL¬ IT¬ WAS¬ DEMONSTRATED¬ THAT¬ &,3¬ OF¬ PATIENTS¬ WITH¬ 2!¬ ATTACH¬ TO¬ AND¬ INVADE¬ IN¬ NORMAL¬CARTILAGE¬ ¬-OREOVER ¬MANY¬GROUPS¬HAVE¬OBSERVED¬THAT¬IN¬2! ¬&,3¬SHOW¬CHAR ACTERISTICS¬ OF¬ TRANSFORMED¬ CELLS¬ LIKE¬ ANCHORAGE¬ INDEPENDENT¬ GROWTH¬ ¬ INSENSITIVITY¬ TO¬ APOPTOSIS ¬AND¬INCREASED¬PROLIFERATION¬0ROCESSES¬THAT¬ARE¬ASSOCIATED¬WITH¬THE¬&,3 CHANGE¬ FROM¬NORMAL¬TO¬AGGRESSIVE¬BEHAVIOUR¬ARE¬PHOSPHORYLATION¬OF¬THE¬SIGNAL¬TRANSDUCER¬AND¬AC TIVATOR¬OF¬TRANSCRIPTION¬34!4 ¬PROTEIN¬AND¬ELEVATED¬LEVELS¬OF¬THE¬PRO ONCOGENE¬C MYC¬ 7HETHER¬THESE¬FEATURES¬ARE¬NON¬CAUSAL¬ASSOCIATIONS¬OR¬A¬CAUSAL¬FACTOR¬IS¬NOT¬YET¬KNOWN¬&,3 IN¬CULTURE¬EXPRESS¬LARGE¬AMOUNTS¬OF¬PROTEASES¬WHICH¬CAN¬DEGRADE¬EXTRACELLULAR¬MATRIX¬COM PONENTS¬SUCH¬AS¬COLLAGENS¬/NE¬FAMILY¬OF¬PROTEASES¬THAT¬IS¬EXPRESSED¬BY¬&,3¬ARE¬THE¬MATRIX METALLOPROTEINASES¬--0S ¬&,3¬EXPRESS¬--0 ¬ ¬ ¬AND¬ ¬AND¬EXPRESSION¬OF¬THESE¬ --0S¬CORRELATE¬WITH¬INVASION¬ ¬/THER¬PROTEASE¬FAMILIES¬THAT¬ARE¬EXPRESSED¬IN¬2!¬&,3¬ARE¬ THE¬CATHEPSINS¬AND¬!$!-S¬A¬DISINTEGRIN¬AND¬METALLOPROTEINASE ¬&,3¬FROM¬PATIENTS¬WITH 2!¬EXPRESS¬SEVERAL¬ONCOGENES¬AT¬HIGHER¬LEVELS¬THAN¬&,3¬FROM¬NORMAL¬CONTROLS¬/NCOGENES¬ THAT¬ARE¬UPREGULATED¬IN¬2!¬ARE¬C MYC¬ ¬2AS¬ ¬AND¬P¬ ¬4HESE¬DATA¬HAVE¬LED¬TO THE¬SUGGESTION¬THAT¬ASPECTS¬OF¬BEHAVIOUR¬OF¬&,3¬IN¬2!¬RESEMBLE¬MALIGNANT¬TISSUE¬(OWEVER¬ WHETHER¬THE¬TRANSFORMED¬BEHAVIOUR¬IS¬OF¬RELEVANCE¬FOR¬THE¬DISEASE¬CHARACTERISTICS¬OF¬2! AND¬IF¬SO¬FOR¬WHICH¬CHARACTERISTICS¬HAS¬NOT¬BEEN¬STUDIED¬4HE¬PRESENT¬STUDY¬INVESTIGATES¬THE ASSOCIATION¬OF¬IN¬VITRO¬CHARACTERISTICS¬OF¬&,3¬WITH¬DISEASE¬CHARACTERISTICS¬IN¬2!¬PATIENTS¬7E¬ PARTICULAR¬ADRESSED¬THE¬QUESTIONS¬ ¬WHETHER¬THE¬DEGREE¬OF¬&,3¬INVASION¬IS¬COMPARABLE¬IN DIFFERENT¬JOINTS¬OF¬THE¬SAME¬PATIENT ¬IE¬IS¬THE¬&,3¬INVASIVENESS¬A¬CHARACTERISTIC¬OCCURRING¬AT¬ MULTIPLE¬JOINTS¬OF¬THE¬SAME¬PATIENT¬OR¬RATHER¬A¬RANDOM¬PROCESS ¬AND¬ ¬WHETHER¬THE¬DEGREE OF¬IN¬VITRO¬INVASION¬IS¬CORRELATED¬WITH¬THE¬DEGREE¬OF¬RADIOLOGICAL¬DESTRUCTION -!4%2)!,3¬!.$¬-%4(/$3 0ATIENTS¬AND¬SYNOVIUM
!SSOCIATION¬BETWEEN¬&,3¬INVASIVENESS¬AND¬2!¬SEVERITY
AND¬ LEAST¬ INVASIVE¬ &,3¬ ¬ PATIENTS ¬ WERE¬ SCORED¬ ACCORDING¬ TO¬ THE¬ 3HARPVAN¬ DER¬ (EIJDE¬ METHOD¬ ¬4HE¬PERSON¬THAT¬SCORED¬THE¬RADIOGRAPHS¬WAS¬UNAWARE¬OF¬THE¬CLINICAL¬DATA¬AND¬ STUDY¬QUESTION¬4HE¬TOTAL¬EROSION¬AND¬JOINT¬SPACE¬NARROWING¬SCORES ¬AS¬WELL¬AS¬THE¬TOTAL 3HARP VAN¬DER¬(EIJDE¬SCORES ¬WERE¬DIVIDED¬BY¬THE¬DISEASE¬DURATION¬FROM¬DATE¬OF¬DIAGNOSIS¬ TO¬DETERMINE¬THE¬RADIOLOGICAL¬PROGRESSION¬PER¬YEAR¬ 3TATISTICAL¬ANALYSIS $IFFERENCES¬IN¬INVASIVENESS¬OF¬&,3¬BETWEEN¬PATIENTS ¬DIFFERENCES¬BETWEEN¬INTRA INDIVIDUAL¬ AND¬INTER INDIVIDUAL¬VARIATION¬AND¬THE¬RADIOLOGICAL¬SCORES¬OF¬THE¬PATIENTS¬WITH¬THE¬MOST¬ AND¬LESS¬INVASIVE¬DISEASE¬WERE¬COMPARED¬WITH¬THE¬-ANN 7HITNEY¬TEST 2%35,43
&,3¬ WERE¬ ISOLATED¬ FROM¬ THESE¬ TISSUES¬ AND¬ CULTURED¬ 7HEN¬ THE¬ CELLS¬ HAD¬ GROWN¬ TO¬ CON m¬UENCY ¬THE¬CELLS¬WERE¬HARVESTED¬AND¬TESTED¬FOR¬INVASIVENESS¬AS¬DESCRIBED¬BEFORE¬ ¬2! &,3¬ WERE¬ SIGNIl¬CANTLY¬ MORE¬ INVASIVE¬ THAN¬ /!¬ &,3¬ IN¬ THIS¬ ASSAY¬ P ¬ ¬ MEAN¬ ¢¬ 3$¬ ¢¬AND¬¢¬FOR¬/!¬AND¬2!¬RESPECTIVELY¬&IGURE¬ ¬4HESE¬RESULTS¬ARE¬IN¬LINE¬ WITH¬PREVIOUS¬STUDIES¬
4HEN¬ IT¬ WAS¬ STUDIED¬ WHETHER¬ THE¬ INVASIVENESS¬ OF¬ &,3¬ FROM¬ DIFFERENT¬ JOINTS¬ OPERATED¬ AT DIFFERENT¬ TIMES¬ EXHIBIT¬ THE¬ SAME¬ INVASIVE¬ CHARACTERISTICS¬ &ROM¬ ¬ PATIENTS¬ WITH¬ 2! ¬ TWO
# HA P TER¬
!SSOCIATION¬BETWEEN¬&,3¬INVASIVENESS¬AND¬2!¬SEVERITY
$)3#533)/.
4HIS¬STUDY¬SHOWS¬THAT¬IN¬2!¬THE¬INTRA INDIVIDUAL¬VARIATION¬IN¬&,3¬INVASIVENESS¬IS¬MUCH LESS¬THAN¬THE¬INTER INDIVIDUL¬VARIATION ¬INDICATING¬THAT¬THE¬INVASIVE¬BEHAVIOUR¬IS¬A¬CHARAC TERISTIC¬OF¬AN¬INDIVIDUAL¬2!¬PATIENT¬&URTHERMORE ¬THIS¬STUDY¬SHOWS¬FOR¬THE¬l¬RST¬TIME¬THAT¬ THE¬ IN¬ VITRO¬ &,3¬ INVASIVENESS¬ IS¬ ASSOCIATED¬ WITH¬ RADIOLOGICAL¬ JOINT¬ DESTRUCTION¬ 0ATIENTS¬ WITH¬THE¬LEAST¬INVASIVE¬&,3¬HAVE¬SIGNIl¬CANTLY¬LOWER¬3HARP VAN¬DER¬(EIJDE¬SCORES¬PER¬YEAR DISEASE¬DURATION¬COMPARED¬TO¬THE¬PATIENTS¬WITH¬THE¬MOST¬INVASIVE¬&,3¬4HIS¬SUGGESTS¬THAT THE¬INVASIVE¬BEHAVIOUR¬OF¬&,3¬IS¬OF¬RELEVANCE¬FOR¬THE¬PATHOGENESIS¬OF¬2! 4HE¬l¬NDING¬OF¬A¬RATHER¬LARGE¬VARIATION¬IN¬RATE¬OF¬INVASION¬OF¬&,3¬BETWEEN¬PATIENTS¬IMPLIES¬ THAT¬THE¬MECHANISM¬OR¬PROCESSES¬UNDERLYING¬INVASIVE¬BEHAVIOUR¬DIFFERS¬BETWEEN¬INDIVIDU ALS¬4HE¬MECHANISM¬THAT¬LEADS¬TO¬TRANSFORMATION¬OF¬&,3¬IS¬NOT¬FULLY¬UNDERSTOOD 0REVIOUS¬STUDIES¬HAVE¬SHOWN¬A¬MYRIAD¬OF¬ALTERATIONS¬IN¬THE¬BEHAVIOUR¬OF¬&,3¬IN¬2!¬/NE VERY¬ STRIKING¬ CHANGE¬ IN¬ &,3¬ IS¬ THE¬ EXPRESSION¬ OF¬ ONCOGENES¬ ¬ /NCOGENES¬ THAT¬ ARE¬ UPREGULATED¬ IN¬ 2!¬ ARE¬ C MYC¬ ¬ ¬ 2AS¬ ¬ P¬ ETC¬ )NHIBITION¬ OF¬ THE¬ 2AS¬ PATHWAY¬ REDUCED¬EXPRESSION¬OF¬--0 ¬AND¬--0 ¬)NHIBITION¬OF¬BOTH¬2AS¬AND¬C MYC¬PATHWAYS ALSO¬REDUCED¬INVASION¬INTO¬NORMAL¬HUMAN¬CARTILAGE¬IN¬THE¬3#)$¬MOUSE¬COIMPLANTATION MODEL¬ ¬!ND¬IT¬IS¬DEMONSTRATED¬THAT¬DOWN REGULATION¬OF¬P¬INm¬UENCES¬PROLIFERATION AND¬INVASION¬OF¬2!¬&,3¬ ¬4RANSFORMATION¬OF¬&,3¬IS¬DIFFERENT¬IN¬DIFFERENT¬INDIVIDUALS ¬ SUGGESTING¬THAT¬A¬GENETIC¬COMPONENT¬PLAYS¬A¬ROLE
# HA P TER¬ 2%&%2%.#%3 ¬ ¬ -ULLER ,ADNER¬5 ¬+RIEGSMANN¬* ¬&RANKLIN¬". ¬-ATSUMOTO¬3 ¬'EILER¬4 ¬'AY¬2%¬ET¬AL¬3Y NOVIAL¬ l¬BROBLASTS¬ OF¬ PATIENTS¬ WITH¬ RHEUMATOID¬ ARTHRITIS¬ ATTACH¬ TO¬ AND¬ INVADE¬ NORMAL¬ HUMAN¬CARTILAGE¬WHEN¬ENGRAFTED¬INTO¬3#)$¬MICE¬!M¬*¬0ATHOL¬¬ ¬ ¬ ¬ ,AFYATIS¬2 ¬2EMMERS¬%& ¬2OBERTS¬!" ¬9OCUM¬$% ¬3PORN¬-" ¬7ILDER¬2,¬!NCHORAGE INDE PENDENT¬GROWTH¬OF¬SYNOVIOCYTES¬FROM¬ARTHRITIC¬AND¬NORMAL¬JOINTS¬3TIMULATION¬BY¬EXOG ENOUS¬PLATELET DERIVED¬GROWTH¬FACTOR¬AND¬INHIBITION¬BY¬TRANSFORMING¬GROWTH¬FACTOR BETA¬ AND¬RETINOIDS¬*¬#LIN¬)NVEST¬¬
¬ ¬ +RAUSE¬ ! ¬ 3CALETTA¬ . ¬ *I¬ *$ ¬ )VASHKIV¬ ,"¬ 2HEUMATOID¬ ARTHRITIS¬ SYNOVIOCYTE¬ SURVIVAL¬ IS DEPENDENT¬ON¬3TAT¬*¬)MMUNOL¬¬ ¬ ¬ 4OLBOOM¬4# ¬0IETERMAN¬% ¬6AN¬$ER¬,AAN¬7( ¬4OES¬2% ¬(UIDEKOPER¬!, ¬.ELISSEN¬2'¬ET¬AL¬ )NVASIVE¬PROPERTIES¬OF¬l¬BROBLAST LIKE¬SYNOVIOCYTES¬CORRELATION¬WITH¬GROWTH¬CHARACTERIS TICS¬AND¬EXPRESSION¬OF¬--0 ¬--0 ¬AND¬--0 ¬!NN¬2HEUM¬$IS¬¬ ¬ ¬ 4RABANDT¬! ¬!ICHER¬7+ ¬'AY¬2% ¬3UKHATME¬60 ¬.ILSON (AMILTON¬- ¬(AMILTON¬24¬ET¬AL %XPRESSION¬OF¬THE¬COLLAGENOLYTIC¬AND¬2AS INDUCED¬CYSTEINE¬PROTEINASE¬CATHEPSIN¬,¬AND¬ PROLIFERATION ASSOCIATED¬ ONCOGENES¬ IN¬ SYNOVIAL¬ CELLS¬ OF¬ -2,)¬ MICE¬ AND¬ PATIENTS¬ WITH¬ RHEUMATOID¬ARTHRITIS¬-ATRIX¬¬ ¬ ¬ 4AK¬00 ¬3MEETS¬4* ¬"OYLE¬$, ¬+RAAN¬-# ¬3HI¬9 ¬:HUANG¬3¬ET¬AL¬P¬OVEREXPRESSION¬IN¬SY NOVIAL¬TISSUE¬FROM¬PATIENTS¬WITH¬EARLY¬AND¬LONGSTANDING¬RHEUMATOID¬ARTHRITIS¬COMPARED WITH¬PATIENTS¬WITH¬REACTIVE¬ARTHRITIS¬AND¬OSTEOARTHRITIS¬!RTHRITIS¬2HEUM¬¬ ¬ ¬ &IRESTEIN¬'3 ¬.GUYEN¬+ ¬!UPPERLE¬+2 ¬9EO¬- ¬"OYLE¬$, ¬:VAIm¬ER¬.*¬!POPTOSIS¬IN¬RHEUMA TOID¬ARTHRITIS¬P¬OVEREXPRESSION¬IN¬RHEUMATOID¬ARTHRITIS¬SYNOVIUM¬!M¬*¬0ATHOL¬ ¬ ¬ VAN¬DER¬(EIJDE¬$-¬0LAIN¬8 RAYS¬IN¬RHEUMATOID¬ARTHRITIS¬OVERVIEW¬OF¬SCORING¬METHODS ¬ THEIR¬RELIABILITY¬AND¬APPLICABILITY¬"AILLIERES¬#LIN¬2HEUMATOL¬¬ ¬ ¬ ¬ 3TRAND¬ 6 ¬ ,ANDEWE¬ 2 ¬ VAN¬ DER¬ (EIJDE¬ $¬ 5SING¬ ESTIMATED¬ YEARLY¬ PROGRESSION¬ RATES¬ TO
COMPARE¬ RADIOGRAPHIC¬ DATA¬ ACROSS¬ RECENT¬ RANDOMISED¬ CONTROLLED¬ TRIALS¬ IN¬ RHEUMATOID¬ ARTHRITIS¬!NN¬2HEUM¬$IS¬¬¬)) ))
